APA (7th ed.) Citation
(2026). Gemini Surfactant-Lipid-Based Nanovesicles (“GeminiSomes”) for Oral Delivery of Silybin: A Promising Strategy for Hepatoprotective Therapy. BioNanoScience.
Chicago Style (17th ed.) Citation
"Gemini Surfactant-Lipid-Based Nanovesicles (“GeminiSomes”) for Oral Delivery of Silybin: A Promising Strategy for Hepatoprotective Therapy." BioNanoScience 2026.
MLA (9th ed.) Citation
"Gemini Surfactant-Lipid-Based Nanovesicles (“GeminiSomes”) for Oral Delivery of Silybin: A Promising Strategy for Hepatoprotective Therapy." BioNanoScience, 2026.
Warning: These citations may not always be 100% accurate.